CSL

Medical Science Liason - Recife, PE

Brazil

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Medical Scientific Liaison

Employment Type: Full-time

Position Overview

Reporting to the Medical Affairs Manager, the Medical Scientific Liaison (MSL) will represent Medical Affairs externally to establish and maintain medical relationships with Key Opinion Leaders (KOLs), Healthcare Professionals (HCPs), and key accounts on behalf of Vifor Pharma Group. The MSL will execute country medical plans locally by representing medical expertise in Therapeutic Areas (TAs) and products, and through scientific engagement with the medical community. Responsibilities include providing disease state education, medical information, and research support, as well as sharing scientific insights from medical community interactions with local and global medical teams, ensuring the capture of field medical expertise. The MSL will also train colleagues internally, all in accordance with global and local compliance and regulations.

Location Requirement: The ideal candidate must reside in Recife - PE to be considered.

Responsibilities

  • Develop and maintain scientific and medical expertise in TAs and products.
  • Identify, develop, and maintain relationships with KOLs, HCPs, and professional organizations.
  • Engage with KOLs, provide key account medical support, training, and conduct other appropriate activities.
  • Facilitate scientific engagement, scientific exchange, and medical information dissemination.
  • Provide Disease State Education and clinical presentations, and respond to medical information requests.
  • Update the medical team and other internal stakeholders on interactions with the medical community.
  • Partner with the sales team to ensure consistent and updated product information is shared with HCPs.
  • Provide medical support for patient and formulary access products, adhering to global and local policies and procedures.
  • Support the development, implementation, and completion of medical activities, including advisory boards, congress symposia, hospital meetings, and speaker programs.
  • Serve as a medical resource for internal medical and sales training.
  • Support company-sponsored clinical research and the Investigator-Initiated Studies (IIS) process.
  • Attend relevant scientific meetings and conferences, and support the development of summaries of key data, presentations, or symposia.
  • Ensure compliance with applicable local and global laws, regulations, guidelines, and company policies and procedures.
  • Develop personal and professional capabilities to enhance skills and professional growth.

Skills and Experience

  • University degree in a Medical or Life Science Field (e.g., Medicine, Pharmacy, Biology/Biochemistry).
  • Minimum of 3 years of experience in clinical practice, research, or the pharmaceutical industry.
  • Demonstrated experience in KOL, HCP, or medical community engagement.
  • Excellent oral and written communication skills in Portuguese.
  • Experience with digital communication.
  • Good oral and written communication skills in English.
  • Experience in public scientific presentations.
  • Ability for overnight travel, up to 30%.

About CSL Vifor

CSL Vifor aims to become the global leader in iron deficiency and nephrology. The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions across iron, dialysis, nephrology, and rare conditions. CSL Vifor strives to help patients around the world with severe, chronic, and rare diseases lead better, healthier lives. It specializes in strategic global partnering, in-licensing and developing, manufacturing, and marketing pharmaceutical products for precision patient care.

For more information, please visit viforpharma.com.

Inclusion and Belonging at CSL:

CSL strives to reflect the world around us. Inclusion and Belonging are at the core of CSL's mission and identity, fueling innovation daily. By celebrating differences and fostering a culture of curiosity and empathy, CSL better understands and connects with patients and donors, builds strong stakeholder relationships, and sustains a diverse workforce to advance the company and industry.

Learn more about Inclusion and Belonging at CSL: Inclusion and Belonging | CSL.

Do work that matters at CSL Vifor!

Skills

Medical Affairs
Key Opinion Leader (KOL) engagement
Healthcare Professional (HCP) engagement
Disease state education
Medical information
Scientific exchange
Clinical presentations
Advisory boards
Congress symposia
Speaker programs
Clinical research support
Investigator-Initiated Studies (IIS)
Medical training

CSL

Develops biotherapies and influenza vaccines

About CSL

CSL develops and delivers biotherapies and influenza vaccines, focusing on rare and serious diseases. Their products include plasma-derived and recombinant therapies, which are created through extensive research and development. CSL serves a wide range of clients, including healthcare providers and governments, across the Americas, Asia Pacific, and Europe. What sets CSL apart from competitors is its comprehensive portfolio and commitment to addressing rare diseases, alongside a strong emphasis on diversity and inclusion within its workforce. The company's goal is to save lives and protect health through its innovative therapies and vaccines.

Parkville, AustraliaHeadquarters
1916Year Founded
$2,628.7MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Emerging synthetic biomaterials may reduce demand for traditional plasma therapies.
Jumar Bioincubator could increase local competition in the biotech sector.
CSL may need to adapt to the rising effectiveness of cell-based influenza vaccines.

Differentiation

CSL offers the broadest range of plasma-derived and recombinant therapies globally.
CSL's self-amplifying mRNA COVID-19 vaccine provides longer immunity at lower doses.
CSL's MF59® adjuvant enhances immune response, crucial for pandemic preparedness.

Upsides

CSL's garadacimab could be the first monthly treatment for hereditary angioedema.
CSL's cell-based influenza vaccine shows higher effectiveness over egg-based vaccines.
CSL's gene therapy HEMGENIX® offers a one-time treatment for haemophilia B.

Land your dream remote job 3x faster with AI